4.7 Article

Phenylphthalazines as small-molecule inhibitors of urea transporter UT-B and their binding model

Journal

ACTA PHARMACOLOGICA SINICA
Volume 37, Issue 7, Pages 973-983

Publisher

NATURE PUBL GROUP
DOI: 10.1038/aps.2016.4

Keywords

urea transport; UT-B; small-molecule inhibitor; phenylphthalazines; drug discovery; stopped-flow light scattering; in silico

Funding

  1. National Natural Science Foundation of China [81500535, 30870921, 31200869, 81170632]
  2. Leading Academic Discipline Project of Beijing Education Bureau [BMU20110254]
  3. Drug Discovery Program grant [2009ZX09301-010-30]
  4. Doctoral Training Fund [20100001110047]
  5. 111 Project, the International Science & Technology Cooperation Program of China [2012DFA11070]
  6. Scientific and Technological Research Program of Chongqing Municipal Education Commission [KJ120330, KJ120314]
  7. Scientific and Technological Research Program of Chongqing Yuzhongqu Scientific and Technological Commission [20120202]
  8. Chongqing Science and Technology Commission [cstc2015jcyjA10036]
  9. China Medical University Hospital and Asia University [DMR-104-118, DMR-104-084, Asia102-CMU-1, Asia102-CMU-2, Asia102-CMU-3]
  10. Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW105-TDU-B-212-133019]

Ask authors/readers for more resources

Aim: Urea transporters (UT) are a family of transmembrane proteins that specifically transport urea. UT inhibitors exert diuretic activity without affecting electrolyte balance. The purpose of this study was to discover novel UT inhibitors and determine the inhibition mechanism. Methods: The primary screening urea transporter B (UT-B) inhibitory activity was conducted in a collection of 10 000 diverse small molecules using mouse erythrocyte lysis assay. After discovering a hit with a core structure of 1-phenylamino-4-phenylphthalazin, the UT-B inhibitory activity of 160 analogs were examined with a stopped-flow light scattering assay and their structure-activity relationship (SAR) was analyzed. The inhibition mechanism was further investigated using in silico assays. Results: A phenylphthalazine compound PU1424, chemically named 5-(4-((4-methoxyphenyl) amino) phthalazin-1-yl)-2-methylbenzene sulfonamide, showed potent UT-B inhibition activity, inhibited human and mouse UT-B-mediated urea transport with IC50 value of 0.02 and 0.69 mu mol/L, respectively, and exerted 100% UT-B inhibition at higher concentrations. The compound PU1424 did not affect membrane urea transport in mouse erythrocytes lacking UT-B. Structure-activity analysis revealed that the analogs with methoxyl group at R4 and sulfonic amide at R2 position exhibited the highest potency inhibition activity on UT-B. Furthermore, in silico assays validated that the R4 and R2 positions of the analogs bound to the UT-B binding pocket and exerted inhibition activity on UT-B. Conclusion: The compound PU1424 is a novel inhibitor of both human and mouse UT-B with IC50 at submicromolar ranges. Its binding site is located at the So site of the UT-B structure.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available